¼Û½ÂÈÆ
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : ºÎÀÎÁ¾¾çÇÐ, ·Îº¿¼ö¼ú
Á÷
ˤ
: ±³¼ö
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
33
±¹³»
Sim CH, Lee JH, Kwak JS,
Song SH.
Necortizing ruptured vaginal leiomyoma micking a malignant neolplasm. Obstet Gynecol Sci 2014 Nov; 57(6):560-3.
32
ÇØ¿Ü
Bone mineral density in patients with uterine cervical cancer after concurrent chemoradiation
31
ÇØ¿Ü
Giant endocervical polyp mimicking cervical malignancy: primary excision and hysteroscopic resection
30
±¹³»
The utility of the human papillomavirus DNA load for the diagnosis and prediction of persistent vaginal intraepithelial neoplasia.
29
ÇØ¿Ü
Unilateral Ovarian Dermoid Cyst Accompanied by an Ipsilateral Paratubal Cyst in a Girl with Proteus Syndrome Discovered by Laparoscopic Surgery.
28
±¹³»
Comparison of the novel human papillomavirus 4 auto-capillary electrophoresis test with the hybrid capture 2 assay and with the PCR HPV typing set test in the detection of high-risk HPV including HPV 16 and 18 genotypes in cervical specimens.
27
ÇØ¿Ü
Comparison of human papillomavirus detection and typing by hybrid capture 2, linear array, DNA chip, and cycle sequencing in cervical swab samples.
26
±¹³»
Ç×¾ÏÄ¡·á¿¡ ¹ÝÀÀÇÏ´Â ³¼Ò¾Ï ȯÀÚ¿¡¼ Ç×-YoÇ×ü°¡ ÀÖ´Â ºÎ½Å»ý¹° ¼Ò³úÅðÇàÁõ 1¿¹
25
ÇØ¿Ü
Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005).
24
ÇØ¿Ü
Interferon-¥ã (IFN-¥ã) a Possible Prognostic Marker for Clearance of High-Risk Human Papillomavirus (HPV)
1
2
3
4
5
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729